INTRODUCTION
============

Medical laboratories play a central role in health care. Laboratory data are an integral part of physicians\' decision-making processes; 70% of all critical medical decisions are based on laboratory test results \[[@B1]\]. The purpose of a laboratory is to provide physicians and other health care professionals with information that enables them to: (1) detect a disease or predisposition to a disease, (2) confirm or reject a diagnosis, (3) establish prognosis, (4) guide patient management, and (5) monitor the efficacy of therapy. To successfully achieve these goals, every laboratory should strive to achieve medical, scientific, and technical expertise, obtain resources such as personnel, laboratory equipment, supplies, and facilities, and, most importantly, have a management set-up that ensures quality laboratory services.

Many laboratories are adopting a more focused and stringent approach to quality system management. The International Organization for Standardization (ISO) is the first quality management system for medical laboratories. It establishes guidelines that reflect the highest level of quality \[[@B2]\]. The ISO 15189 has been adopted by the College of American Pathologists (CAP) in an effort to improve patient care through quality laboratory practices \[[@B3]\]. Similarly, the CLSI has developed 12 Quality System Essentials based on ISO standards. These 12 essentials serve as a starting point in establishing a quality system that covers pre-testing, testing, and post-testing operations \[[@B3]\]. In the United States, laboratory activities are highly regulated by healthcare-related legislation such as the Clinical Laboratory Improvement Amendments (CLIA) of 1988 \[[@B4]\]. Most clinical laboratories in the United States have received CLIA certification to perform testing on human samples, which indicates that they meet personnel, operational, safety, and quality standards based on test complexity.

In Korea, no national regulatory standards have been developed for clinical laboratories. The standardization of laboratory practice depends on a private sector entity, the Korean Laboratory Accreditation Program (KLAP), and the Korean External Quality Assessment Scheme (KEQAS) \[[@B5][@B6]\]. The KLAP was developed by the Korean Society of Laboratory Medicine in 1999, and was reorganized as the Laboratory Medicine Foundation in 2010 \[[@B6]\]. A laboratory that meets the requirements of laboratory accreditation schemes can receive KLAP certification, which expresses confidence in the quality of services provided by that laboratory \[[@B6]\]. The KEQAS was set up in 1976, and is currently run by the Korean Association of External Quality Assessment Service. The main objectives of the KEQAS are to compare test results among participating laboratories nationwide by using the same test item. The number of participants in the KEQAS is gradually increasing \[[@B5]\].

The standardization efforts undertaken by the KLAP and KEQAS may have facilitated an improvement in laboratory performance in Korea; however, there are no fundamental studies demonstrating that laboratory standardization is useful. We analyzed the results of the KEQAS to identify significant differences between laboratories with and without KLAP, and to determine the impact of laboratory practice standardization on the accuracy of diagnostic testing.

METHODS
=======

1. Study subjects and parameters
--------------------------------

Data from the KEQAS gathered between 2010 and 2013 by the clinical chemistry subcommittee of the Korean Association of External Quality Assessment Service were included in this study. A total of 19 test items related to clinical chemistry were analyzed: albumin, alkaline phosphatase, ALT, AST, blood urea nitrogen, chloride, creatinine, γ-glutamyl transferase, glucose, lactate dehydrogenase, phosphorus, potassium, sodium, total bilirubin, total calcium, total cholesterol, total protein, triglyceride, and uric acid \[[@B7]\]. As a statistical parameter to assess bias in performance between laboratories, we used the variance index score (VIS). The VIS ranges from 0 to 400, and it provides an overall comparison of test results for each test item. The value of the VIS is calculated as follows: VIS=\[(X~lab~--DV)/DV×100\]/CCV×100; where X~lab~ is the result from the participating laboratory; DV is the designated value, which is the mean result from the participating laboratories using that method after excluding outliers more than two standard deviations from the mean; and CCV is the chosen coefficient of variation, taken from the National External Quality Assessment Scheme in the United Kingdom (1971) \[[@B8]\].

2. Comparison of 4-yr VIS between laboratories with or without KLAP
-------------------------------------------------------------------

KEQAS participants, whose data on clinical chemistry tests were available, were categorized into two subgroups based on their KLAP status, and the VIS of each test item from 2010--2013 was compared. The number of laboratories participating in the KEQAS was 1,333 in 2013 \[[@B7]\]. Among the KEQAS participants with available data, the number of laboratories with or without KLAP, by year, was 233/767 (23% accredited; 77% non-accredited) in 2010, 245/844 (22% accredited; 78% non-accredited) in 2011, 258/908 (22% accredited; 78% non-accredited) in 2012, and 265/1,008 (21% accredited; 79% non-accredited) in 2013.

3. Comparison of 4-yr VIS between laboratories categorized by institution type
------------------------------------------------------------------------------

All participants in the KEQAS were categorized into four laboratory subgroups based on the institutional type; these subgroups were general hospitals with 100 or more beds, hospitals with 30--99 beds, clinics with less than 30 beds, and entrusted laboratory agencies. During 2010--2013, the number of laboratories in general hospitals varied between 321 and 356; the number of laboratories in hospitals varied between 314 and 453; the number of laboratories in clinics varied between 272 and 351; and the number laboratories in entrusted laboratory agencies varied between 11 and 15. We analyzed the VIS difference in each test by institutional type. Furthermore, we analyzed the difference in VIS between laboratories in general hospitals based on their KLAP status to rule out confounding factors such as personnel, laboratory equipment, supplies, and facilities. These factors are likely to affect the value of the VIS, because the hospital and clinic institutional types had a very small number of KLAP-accredited laboratories. Therefore, only data from the general hospital group, which had a sufficient number of laboratories with or without KLAP spanning, were included in further analysis.

4. Statistical analysis
-----------------------

VIS differences between laboratories with or without KLAP were compared by Student\'s t-test. One-way ANOVA followed by Tukey\'s multiple comparison test was used to evaluate the statistical significance of the differences among the institutional types. Logarithmic transformation of VIS was performed because of its right skewed distribution. The values of VIS were reported as the geometric mean with 95% confidence intervals. *P* values were based on two-sided comparisons, and *P* values\<0.05 were considered statistically significant.

RESULTS
=======

1. Differences in the VIS between laboratories with or without KLAP
-------------------------------------------------------------------

Statistical data on VIS, by test, are listed in [Table 1](#T1){ref-type="table"}. Most of the VIS data received scores of less than 100, except for a chloride test result from laboratories without KLAP (107.7 in 2010, 101.9 in 2011, and 102.3 in 2012). Relative to the group of laboratories without KLAP, the group of laboratories with KLAP exhibited significantly lower geometric means of 4-yr VIS in all tests (*P*\<0.0001). Confidence intervals for the mean of each test item in the two groups (accredited and non-accredited) did not overlap; this gap suggested that the means of the two groups were significantly different ([Table 1](#T1){ref-type="table"}). The geometric means of VIS in 2013 are shown in [Fig. 1](#F1){ref-type="fig"}.

2. Differences in the VIS between laboratories categorized by institution type
------------------------------------------------------------------------------

Laboratories in general hospitals and entrusted laboratory agencies exhibited significantly lower geometric means of 4-yr VIS for all test items compared with that of laboratories in hospitals and clinics (*P*\<0.0001) ([Table 2](#T2){ref-type="table"}). The laboratories in general hospitals were further classified into two subgroups based on their KLAP status; the numbers in the accredited and non-accredited groups were 205 (64%) and 116 (36%) in 2010, 212 (65%) and 116 (35%) in 2011, 219 (66%) and 113 (34%) in 2012, and 221 (62%) and 135 (38%) in 2013, respectively. Among the laboratories in general hospitals, the means of 4-yr VIS in laboratories with KLAP were significantly lower than those in laboratories without KLAP for blood urea nitrogen, chloride, creatinine, glucose, lactate dehydrogenase, phosphorus, potassium, sodium, total calcium, total cholesterol, triglyceride, and uric acid ([Table 3](#T3){ref-type="table"}).

DISCUSSION
==========

The major finding of this study is that the 4-yr VIS was significantly different between laboratories with or without KLAP. The VIS scores in KLAP-accredited laboratories were significantly lower than those in laboratories without KLAP for all clinical chemistry tests; this difference justifies a high level of confidence in standardized services provided by accredited laboratories. The present study is the first to demonstrate a strong impact of practice standardization on the accuracy of test results.

Implementation of laboratory standards is verified through the process of accreditation. In many countries, accreditation of medical laboratories has been established for several decades \[[@B9][@B10][@B11][@B12]\]. Accredited medical laboratories should have a well-functioning quality management system, demonstrate technical competence, and provide timely and customer-focused services that contribute to patient care. Our observation of a lower VIS in KLAP-accredited laboratories suggests that the KLAP assesses laboratories in accordance with the accepted standards. This finding provides external validation that KLAP-accredited laboratory services are accurate, traceable, and reproducible.

Clinical laboratories must provide high-quality services by producing accurate, precise, relevant, and comprehensive data, which have a direct impact on the medical management of patients \[[@B1]\]. Enhancement of the quality of laboratory services involves laboratory quality management plans, including pre-analytic, analytic, and post-analytic plans, and standardization of activities and practices. A lack of standardization makes it impossible to guarantee the reliability or accuracy of laboratory test results, which increases the error rate and endangers patient safety \[[@B13]\]. Laboratory standards critical to patient safety include proficiency testing, laboratory accreditation, continuing education, safety goals, health information technology use, and electronic records. Therefore, accreditation bodies, consisting of independent entities as well as government authorities, should work to improve the quality of laboratory practices and patient safety.

We used the VIS statistical parameter, obtained from the KEQAS, to assess the standardized performance of different laboratories. One could argue that the parameter accurately reflects laboratory standardization, because the KEQAS is run by a voluntary organization, and not government authorities. However, the KEQAS has great value in quality assessment, allowing a laboratory to confirm that its results are consistent with those of other laboratories using the same or similar methods, and thus to confirm that it is correctly following the methods \[[@B14]\]. It is also important for maintaining long-term accuracy of analytical methods, and thus, it was chosen as a parameter to assess the effect of standardization.

In conclusion, our investigation of the KEQAS data confirmed that practice standardization is strongly associated with the accuracy of test results. Our analysis emphasizes the necessity of establishing a system for providing standardized diagnostic testing.
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![Comparison of geometric means of the variance index score (VIS) for clinical chemistry tests between laboratories with or without KLAP in 2013. The 95% confidence intervals for the mean of each test in the two groups did not overlap. (A) VIS\<50 and (B) VIS: 50--100. The graph shows the clinical chemistry tests on the X-axis and the geometric means of the VIS on the Y-axis.\
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###### Comparison of variance index scores between laboratories with or without KLAP from 2010 to 2013

![](alm-37-213-i001)

  Test item                Year   Accredited laboratory   Non-accredited laboratory   *P*^‡^                                       
  ------------------------ ------ ----------------------- --------------------------- --------------------- ---------------------- -----------
  Albumin                  2010   232                     40.9 (38.7--43.2)           722                   47.6 (45.7--49.6)      \< 0.0001
  2011                     244    36.4 (34.3--38.7)       789                         44.3 (42.7--46.0)     \< 0.0001              
  2012                     257    36.3 (34.3--38.5)       845                         45.2 (43.5--46.8)     \< 0.0001              
  2013                     264    38.3 (36.3--40.4)       937                         48.3 (46.7--50.0)     \< 0.0001              
  ALP                      2010   228                     39.8 (36.5--43.3)           696                   50.0 (47.0--53.2)      \< 0.0001
  2011                     240    40.6 (37.4--44.1)       764                         53.3 (50.5--56.2)     \< 0.0001              
  2012                     254    40.5 (37.2--44.1)       815                         50.2 (47.5--53.1)     \< 0.0001              
  2013                     261    43.8 (40.1--47.8)       892                         57.4 (54.4--60.6)     \< 0.0001              
  ALT                      2010   233                     33.2 (31.2--35.4)           767                   38.4 (36.7--40.2)      0.0002
  2011                     245    28.8 (27.0--30.8)       844                         37.1 (35.6--38.7)     \< 0.0001              
  2012                     258    32.7 (30.8--34.7)       908                         41.3 (39.8--42.8)     \< 0.0001              
  2013                     265    33.6 (31.5--35.9)       1,008                       43.3 (41.8--44.9)     \< 0.0001              
  AST                      2010   233                     30.1 (28.2--32.2)           766                   37.1 (35.5--38.7)      \< 0.0001
  2011                     245    27.3 (25.6--29.1)       845                         33.1 (31.9--34.4)     \< 0.0001              
  2012                     257    27.8 (25.9--29.7)       908                         36.0 (34.6--37.3)     \< 0.0001              
  2013                     264    28.1 (26.3--30.1)       1,007                       36.5 (35.1--38.0)     \< 0.0001              
  BUN                      2010   233                     47.0 (44.0--50.2)           735                   63.9 (61.0--67.0)      \< 0.0001
  2011                     245    41.8 (39.3--44.4)       806                         63.3 (60.7--66.1)     \< 0.0001              
  2012                     257    41.8 (39.4--44.3)       859                         62.5 (60.0--65.1)     \< 0.0001              
  2013                     264    42.4 (39.9--45.0)       959                         68.4 (65.7--71.2)     \< 0.0001              
  Chloride                 2010   224                     76.1 (71.5--81.0)           424                   107.7 (102.4--113.3)   \< 0.0001
  2011                     236    75.3 (71.9--78.8)       471                         101.9 (97.5--106.4)   \< 0.0001              
  2012                     248    78.3 (74.6--82.2)       507                         102.3 (97.9--106.9)   \< 0.0001              
  2013                     256    85.0 (81.0--89.2)       561                         99.0 (94.9--103.3)    \< 0.0001              
  Creatinine               2010   228                     45.8 (42.8--48.9)           754                   66.9 (64.1--69.9)      \< 0.0001
  2011                     240    45.7 (43.1--48.3)       829                         61.4 (58.9--64.1)     \< 0.0001              
  2012                     254    45.6 (43.2--48.2)       892                         63.7 (61.1--66.3)     \< 0.0001              
  2013                     261    46.1 (43.6--48.8)       993                         68.2 (65.6--70.8)     \< 0.0001              
  γ-glutamyl transferase   2010   229                     27.6 (25.6--29.6)           749                   36.8 (35.1--38.5)      \< 0.0001
  2011                     241    27.9 (26.0--30.0)       824                         34.5 (33.1--36.0)     \< 0.0001              
  2012                     254    27.8 (26.0--29.8)       886                         33.8 (32.4--35.3)     \< 0.0001              
  2013                     261    27.3 (25.6--29.2)       983                         36.2 (34.8--37.6)     \< 0.0001              
  Glucose                  2010   229                     23.4 (21.9--24.9)           744                   35.9 (34.3--37.6)      \< 0.0001
  2011                     241    23.4 (22.1--24.9)       820                         34.2 (32.8--35.7)     \< 0.0001              
  2012                     254    24.3 (22.8--26.0)       839                         33.8 (32.5--35.3)     \< 0.0001              
  2013                     261    22.5 (21.1--24.1)       981                         34.8 (33.4--36.2)     \< 0.0001              
  LDH                      2010   226                     16.0 (14.3--18.0)           520                   22.8 (20.9--24.8)      \< 0.0001
  2011                     238    13.9 (12.6--15.2)       540                         20.2 (18.7--21.8)     \< 0.0001              
  2012                     250    14.3 (13.2--15.5)       562                         20.3 (18.9--21.7)     \< 0.0001              
  2013                     256    17.2 (15.9--18.5)       604                         23.5 (22.0--25.2)     \< 0.0001              
  Phosphorus               2010   219                     33.4 (31.1--35.9)           283                   45.8 (42.5--49.4)      \< 0.0001
  2011                     231    29.2 (27.3--31.2)       307                         43.8 (40.7--47.2)     \< 0.0001              
  2012                     245    29.7 (27.7--31.9)       326                         40.3 (37.3--43.4)     \< 0.0001              
  2013                     251    28.9 (27.0--30.9)       338                         40.1 (37.2--43.2)     \< 0.0001              
  Potassium                2010   225                     48.9 (45.8--52.3)           438                   73.6 (69.6--77.8)      \< 0.0001
  2011                     237    45.5 (42.7--48.6)       484                         74.7 (71.1--78.5)     \< 0.0001              
  2012                     248    44.6 (42.2--47.2)       519                         66.1 (63.0--69.3)     \< 0.0001              
  2013                     255    43.4 (40.5--46.5)       574                         68.5 (65.3--71.8)     \< 0.0001              
  Sodium                   2010   225                     61.1 (57.0--65.5)           437                   83.6 (79.3--88.2)      \< 0.0001
  2011                     237    61.5 (57.9--65.4)       484                         87.7 (83.5--92.1)     \< 0.0001              
  2012                     249    59.6 (56.4--63.0)       519                         88.4 (84.5--92.6)     \< 0.0001              
  2013                     256    56.4 (53.1--59.9)       574                         84.1 (80.4--87.9)     \< 0.0001              
  Total bilirubin          2010   228                     25.7 (23.8--27.8)           720                   36.9 (34.9--38.9)      \< 0.0001
  2011                     240    28.1 (26.1--30.2)       790                         37.1 (35.4--38.9)     \< 0.0001              
  2012                     254    26.9 (25.0--29.0)       845                         33.7 (32.1--35.4)     \< 0.0001              
  2013                     261    26.5 (24.7--28.5)       942                         36.1 (34.6--37.7)     \< 0.0001              
  Total calcium            2010   220                     53.9 (50.3--57.8)           321                   77.8 (72.9--83.0)      \< 0.0001
  2011                     233    52.7 (49.6--56.0)       348                         79.5 (75.1--84.1)     \< 0.0001              
  2012                     246    52.8 (49.5--56.4)       362                         76.2 (72.1--80.6)     \< 0.0001              
  2013                     251    49.8 (46.7--53.1)       383                         73.2 (68.8--77.9)     \< 0.0001              
  Total cholesterol        2010   233                     28.3 (26.5--30.2)           754                   37.4 (35.7--39.1)      \< 0.0001
  2011                     245    26.7 (25.0--28.4)       829                         35.4 (34.1--36.8)     \< 0.0001              
  2012                     257    26.7 (25.1--28.3)       820                         34.7 (33.3--36.2)     \< 0.0001              
  2013                     264    26.8 (25.2--28.4)       993                         37.5 (36.1--39.0)     \< 0.0001              
  Total protein            2010   233                     57.0 (53.2--60.9)           715                   75.4 (71.8--79.2)      \< 0.0001
  2011                     245    53.1 (50.5--55.9)       780                         74.9 (71.9--78.1)     \< 0.0001              
  2012                     258    51.2 (48.4--54.2)       834                         71.9 (69.0--74.9)     \< 0.0001              
  2013                     265    50.2 (47.4--53.1)       855                         75.5 (72.4--78.8)     \< 0.0001              
  Triglyceride             2010   229                     32.0 (29.3--34.9)           738                   45.1 (42.7--47.5)      \< 0.0001
  2011                     241    35.4 (32.8--38.3)       811                         48.0 (45.5--50.6)     \< 0.0001              
  2012                     246    33.1 (30.7--35.8)       645                         45.6 (43.1--48.3)     \< 0.0001              
  2013                     261    30.3 (28.3--32.4)       975                         45.5 (43.5--47.7)     \< 0.0001              
  Uric acid                2010   228                     32.5 (30.4--34.7)           649                   44.1 (41.9--46.5)      \< 0.0001
  2011                     239    30.2 (28.3--32.2)       701                         42.2 (40.3--44.3)     \< 0.0001              
  2012                     254    28.3 (26.7--30.1)       740                         41.0 (39.2--43.0)     \< 0.0001              
  2013                     261    28.2 (26.6--29.9)       805                         44.1 (42.0--46.2)     \< 0.0001              

^\*^Number of laboratories; ^†^Geometric mean of VIS; ^‡^*P* value by Student\'s t-test using the log-transformed values.

Abbreviations: BUN, blood urea nitrogen; CI, confidence interval; KLAP, Korean Laboratory Accreditation Program; LDH, lactate dehydrogenase; VIS, variance index score.

###### Comparison of variance index scores between laboratories categorized by institution type between 2010 and 2013

![](alm-37-213-i002)

  Test item                Year   General hospital           Hospital                    Clinic                      Entrusted laboratory      *P*^‡^                                                                                                             
  ------------------------ ------ -------------------------- --------------------------- --------------------------- ------------------------- --------------------------- --------------------------- ------------------------------ --------------------------- -----------
  Albumin                  2010   313                        43.0 (40.9--45.3)           312                         46.3 (43.7--49.2)         253                         48.2 (44.7--51.9)           11                             36.4 (29.6--44.6)           0.0302
  2011                     320    37.5^§,∥^ (35.5--39.6)     350                         44.9^§^ (42.6--47.4)        282                       44.5^∥^ (41.6--47.6)        12                          35.5 (26.4--47.7)              \< 0.0001                   
  2012                     324    37.1^§,∥^ (35.2--39.1)     394                         46.5^§,¶^ (44.1--48.9)      302                       45.1^∥,\*\*^ (42.3--48.1)   13                          30.6^¶,\*\*^ (22.2--45.1)      \< 0.0001                   
  2013                     345    39.7^§,∥^ (37.7--41.9)     447                         49.9^§^ (47.5--52.5)        321                       47.3^∥^ (44.6--50.1)        15                          41.9 (33.6--52.1)              \< 0.0001                   
  ALP                      2010   312                        41.3^§^ (38.1--44.9)        308                         47.5 (43.5--51.9)         229                         52.6^§^ (46.9--59.1)        11                             43.9 (26.2--73.4)           0.0058
  2011                     319    43.1^§,∥^ (40.0--46.5)     346                         52.8^§^ (48.9--57.0)        259                       53.5^∥^ (48.5--59.1)        12                          42.7 (28.8--63.4)              0.0007                      
  2012                     323    40.9^§,∥^ (37.7--44.2)     390                         52.1^§^ (48.2--56.3)        274                       49.5^∥^ (44.7--54.8)        13                          47.5 (29.7--75.9)              0.0005                      
  2013                     340    46.6^§^ (43.0--50.5)       436                         59.8^§^ (55.3--64.6)        289                       52.7 (47.9--58.0)           15                          51.2 (31.6--82.7)              0.0004                      
  ALT                      2010   321                        34.3^§^ (32.3--36.4)        314                         38.5 (36.0--41.3)         272                         40.6^§^ (37.6--43.8)        11                             31.8 (25.8--39.2)           0.0042
  2011                     328    31.8^§,∥^ (30.0--33.8)     353                         36.0^§^ (34.0--38.2)        309                       38.3^∥^ (35.5--41.4)        12                          32.0 (23.7--43.1)              0.0010                      
  2012                     332    35.4^§,∥^ (33.5--37.3)     397                         40.0^§^ (38.0--42.2)        335                       42.6^∥,¶^ (40.0--45.3)      13                          27.5^¶^ (21.6--35.0)           \< 0.0001                   
  2013                     356    36.0^§,∥^ (34.0--38.2)     453                         42.9^§^ (40.7--45.2)        351                       44.5^∥^ (41.8--47.5)        15                          38.1 (31.1--46.6)              \< 0.0001                   
  AST                      2010   321                        31.2^§,∥^ (29.4--33.0)      314                         36.9^§^ (34.5--39.4)      271                         38.9^∥^ (36.1--41.9)        11                             27.4 (21.0--35.6)           \< 0.0001
  2011                     328    28.2^§,∥^ (26.6--29.9)     353                         32.3^§^ (30.4--34.2)        309                       35.3^∥^ (33.2--37.5)        12                          29.9 (21.9--40.8)              \< 0.0001                   
  2012                     332    28.7^§,∥^ (27.1--30.5)     397                         35.7^§^ (33.8--37.7)        334                       36.8^∥^ (34.4--39.3)        13                          24.9 (18.9--32.8)              \< 0.0001                   
  2013                     355    29.6^§,∥^ (27.8--31.6)     453                         35.3^§^ (33.3--37.4)        350                       37.8^∥^ (35.3--40.5)        15                          32.4 (24.6--42.8)              \< 0.0001                   
  BUN                      2010   314                        51.2^§,∥^ (48.2--54.3)      313                         63.1^§^ (59.0--67.5)      255                         64.6^∥^ (59.1--70.6)        11                             43.7 (34.0--56.2)           \< 0.0001
  2011                     321    46.4^§,∥^ (43.8--49.1)     352                         62.8^§^ (59.2--66.7)        286                       63.7^∥^ (58.7--69.0)        12                          46.4 (32.7--65.9)              \< 0.0001                   
  2012                     325    45.0^§,∥^ (42.7--47.5)     395                         63.3^§,¶^ (59.9--67.0)      303                       64.5^∥,\*\*^ (59.8--69.5)   13                          38.5^¶,\*\*^ (28.3--52.4)      \< 0.0001                   
  2013                     351    48.1^§,∥^ (45.3--51.1)     448                         69.0^§,¶^ (65.2--73.1)      323                       69.1^∥,\*\*^ (64.2--74.4)   15                          39.2^¶,\*\*^ (29.9--51.5)      \< 0.0001                   
  Chloride                 2010   306                        84.4^§^ (79.8--89.3)        273                         108.3^§^ (101.6--115.3)   45                          98.0 (81.2--118.3)          10                             83.0 (63.5--108.4)          \< 0.0001
  2011                     313    80.4^§,∥^ (77.0--84.0)     311                         104.6^§^ (99.0--110.5)      53                        96.0^∥^ (83.3--110.5)       11                          90.1 (71.5--113.6)             \< 0.0001                   
  2012                     316    85.1^§^ (81.1--89.2)       341                         103.9^§^ (98.4--109.7)      65                        90.3 (79.3--102.8)          12                          76.0 (59.2--97.5)              \< 0.0001                   
  2013                     323    88.3^§^ (84.4--92.4)       386                         98.1^§^ (93.0--103.4)       71                        99.6 (89.6--110.6)          15                          89.2 (68.5--116.2)             0.0213                      
  Creatinine               2010   313                        48.8^§,∥^ (46.1--51.6)      314                         67.0^§,¶^ (62.9--71.5)    271                         69.2^∥,\*\*^ (64.1--74.9)   11                             38.2^¶,\*\*^ (23.1--63.0)   \< 0.0001
  2011                     320    47.4^§,∥^ (44.9--50.0)     353                         61.4^§^ (57.8--65.3)        306                       64.2^∥^ (59.5--69.3)        12                          44.8 (35.9--55.9)              \< 0.0001                   
  2012                     324    48.6^§,∥^ (46.0--51.3)     397                         62.9^§^ (59.3--66.8)        333                       66.9^∥,¶^ (62.4--71.8)      13                          41.9^¶^ (35.4--49.7)           \< 0.0001                   
  2013                     350    51.0^§,∥^ (48.1--54.0)     453                         68.3^§,¶^ (64.8--72.0)      349                       71.3^∥,\*\*^ (66.7--76.1)   15                          38.5^¶,\*\*^ (30.0--49.3)      \< 0.0001                   
  γ-glutamyl transferase   2010   313                        30.5^§,∥^ (28.6--32.5)      311                         36.5^§^ (34.0--39.2)      271                         36.2^∥^ (33.2--39.5)        11                             24.8 (18.0--34.1)           0.0005
  2011                     320    28.2^§,∥^ (26.5--30.1)     348                         35.6^§^ (33.4--37.9)        307                       34.4^∥^ (31.9--37.1)        12                          25.6 (20.6--31.9)              \< 0.0001                   
  2012                     324    29.4^§,∥^ (27.6--31.2)     391                         33.8^§,¶^ (31.8--35.9)      332                       34.2^∥,\*\*^ (31.6--37.0)   13                          19.6^¶,\*\*^ (14.5--26.3)      0.0002                      
  2013                     350    30.5^§,∥,¶^ (28.7--32.4)   443                         35.1^§,\*\*^ (33.2--37.1)   348                       37.0^∥,††^ (34.5--39.6)     15                          19.1^¶,\*\*,††^ (13.9--26.4)   \< 0.0001                   
  Glucose                  2010   313                        26.6^§,∥^ (25.0--28.4)      314                         36.2^§^ (33.9--38.7)      270                         33.9^∥^ (31.2--36.9)        11                             28.2 (21.8--36.3)           \< 0.0001
  2011                     320    25.4^§,∥^ (24.0--26.9)     353                         34.4^§^ (32.4--36.6)        306                       34.5^∥^ (32.1--37.2)        12                          26.9 (22.0--32.9)              \< 0.0001                   
  2012                     324    26.0^§,∥^ (24.5--27.6)     397                         34.1^§,¶^ (32.1--36.1)      330                       34.6^∥,\*\*^ (32.2--37.1)   13                          21.2^¶,\*\*^ (15.6--28.9)      \< 0.0001                   
  2013                     350    26.1^§,∥^ (24.4--28.0)     452                         35.5^§^ (33.5--37.6)        346                       33.2^∥^ (30.8--35.7)        15                          23.6 (17.1--32.5)              \< 0.0001                   
  LDH                      2010   307                        17.2^§^ (15.5--19.1)        239                         24.1^§^ (21.3--27.3)      148                         20.2 (17.2--23.8)           11                             21.7 (10.8--43.9)           0.0007
  2011                     312    15.0^§^ (13.7--16.4)       256                         21.3^§^ (19.0--23.8)        157                       18.3 (15.9--21.1)           12                          16.8 (11.0--25.7)              \< 0.0001                   
  2012                     315    15.2^§,∥^ (14.1--16.4)     284                         20.3^§^ (18.6--22.1)        159                       20.0^∥^ (17.3--23.2)        13                          13.9 (8.0--24.3)               \< 0.0001                   
  2013                     327    19.3^§^ (17.8--20.8)       308                         23.3^§^ (21.2--25.6)        165                       22.2 (19.5--25.4)           14                          13.7 (9.7--19.3)               0.0032                      
  Phosphorus               2010   287                        35.8^§^ (33.6--38.3)        142                         46.8^§^ (42.0--52.1)      53                          45.0 (37.3--54.3)           10                             41.2 (28.2--60.4)           0.0001
  2011                     293    32.1^§,∥^ (30.1--34.3)     159                         42.9^§^ (38.9--47.4)        64                        45.6^∥^ (37.8--54.9)        11                          27.3 (19.7--37.8)              \< 0.0001                   
  2012                     298    31.6^§,∥^ (29.5--33.9)     182                         39.0^§^ (35.3--43.2)        68                        42.6^∥^ (36.2--50.1)        12                          27.5 (18.8--40.3)              0.0001                      
  2013                     303    31.0^§,∥^ (29.1--33.1)     189                         40.3^§,¶^ (36.5--44.4)      72                        39.1^∥,\*\*^ (32.7--46.6)   14                          23.9^¶,\*\*^ (17.1--33.5)      \< 0.0001                   
  Potassium                2010   306                        52.9^§,∥^ (49.8--56.1)      283                         77.3^§,¶^ (72.2--82.9)    49                          76.3^∥^ (63.9--91.1)        11                             48.2^¶^ (36.9--63.0)        \< 0.0001
  2011                     313    49.9^§,∥^ (46.9--53.0)     319                         78.2^§^ (73.6--83.0)        57                        73.9^∥^ (63.4--86.0)        12                          54.8 (44.7--67.2)              \< 0.0001                   
  2012                     315    48.6^§,∥^ (46.0--51.4)     349                         68.2^§,¶^ (64.6--72.1)      69                        60.2^∥^ (51.5--70.4)        13                          43.4^¶^ (33.9--55.7)           \< 0.0001                   
  2013                     322    46.3^§,∥^ (43.4--49.3)     395                         71.2^§^ (67.4--75.3)        74                        63.9^∥^ (55.5--73.6)        15                          49.1 (35.1--68.7)              \< 0.0001                   
  Sodium                   2010   306                        63.9^§,∥^ (60.1--68.0)      283                         85.1^§^ (79.9--90.8)      48                          100.4^∥^ (84.7--119.1)      11                             67.8 (47.5--96.7)           \< 0.0001
  2011                     313    65.3^§,∥^ (61.6--69.2)     319                         88.6^§^ (83.6--93.8)        57                        92.6^∥^ (79.4--108.0)       12                          80.1 (57.4--111.8)             \< 0.0001                   
  2012                     316    62.8^§,∥^ (59.5--66.3)     349                         91.4^§^ (86.6--96.4)        69                        87.5^∥^ (76.8--99.6)        13                          69.4 (52.8--91.3)              \< 0.0001                   
  2013                     323    59.8^§,∥^ (56.6--63.2)     395                         86.1^§,¶^ (81.7--90.8)      74                        81.5^∥,\*\*^ (71.9--92.4)   15                          55.0^¶,\*\*^ (41.1--73.6)      \< 0.0001                   
  Total bilirubin          2010   312                        26.6^§,∥^ (24.9--28.5)      310                         36.8^§,¶^ (33.8--40.0)    248                         40.1^∥,\*\*^ (36.4--44.3)   11                             20.2^¶,\*\*^ (15.4--26.6)   \< 0.0001
  2011                     319    28.7^§,∥^ (26.9--30.7)     350                         37.8^§^ (35.8--40.5)        278                       38.0^∥^ (34.8--41.4)        12                          29.2 (22.1--38.6)              \< 0.0001                   
  2012                     323    27.0^§,∥^ (25.2--29.0)     394                         33.9^§^ (31.7--36.2)        299                       34.4^∥^ (31.4--37.6)        13                          24.2 (19.2--30.5)              \< 0.0001                   
  2013                     348    28.3^§,∥^ (26.4--30.4)     446                         35.1^§^ (33.0--37.3)        319                       37.7^∥^ (35.0--40.7)        15                          26.5 (19.2--36.7)              \< 0.0001                   
  Total calcium            2010   295                        57.8^§,∥^ (54.4--61.5)      164                         81.9^§^ (74.9--89.5)      60                          74.9^∥^ (62.7--89.4)        10                             65.2 (48.5--87.6)           \< 0.0001
  2011                     302    57.6^§,∥^ (54.4--60.9)     185                         82.9^§,¶^ (76.9--89.2)      71                        75.4^∥^ (64.9--87.5)        11                          54.6^¶^ (42.6--69.9)           \< 0.0001                   
  2012                     305    57.6^§,∥^ (54.3--60.9)     205                         79.4^§^ (73.4--85.9)        74                        67.6 (58.8--77.6)           12                          46.5^∥^ (31.5--68.5)           \< 0.0001                   
  2013                     312    52.1^§,∥^ (49.1--55.3)     217                         77.5^§^ (71.3--84.2)        76                        71.8^∥^ (62.5--82.5)        14                          54.8 (44.3--67.8)              \< 0.0001                   
  Total cholesterol        2010   315                        29.2^§,∥^ (27.6--30.9)      314                         37.7^§^ (35.2--40.3)      272                         37.4^∥^ (34.6--40.5)        11                             26.5 (18.1--39.0)           \< 0.0001
  2011                     322    28.4^§,∥^ (26.9--30.0)     351                         36.6^§^ (34.6--38.7)        308                       33.8^∥^ (31.5--36.3)        12                          27.0 (19.4--37.6)              \< 0.0001                   
  2012                     324    27.5^§,∥^ (26.0--29.1)     389                         36.0^§^ (34.0--38.1)        331                       34.5^∥^ (32.1--37.1)        13                          29.8 (24.3--36.5)              \< 0.0001                   
  2013                     352    30.1^§,∥^ (28.3--31.9)     450                         37.7^§^ (35.7--39.9)        349                       36.1^∥^ (33.8--38.6)        15                          26.0 (20.5--32.9)              \< 0.0001                   
  Total protein            2010   314                        59.1^§,∥^ (55.6--62.8)      312                         78.4^§^ (73.3--83.9)      248                         73.8^∥^ (67.0--81.2)        11                             61.5 (48.6--77.7)           \< 0.0001
  2011                     321    58.8^§,∥^ (55.9--61.8)     350                         74.3^§^ (70.1--78.7)        275                       75.1^∥^ (69.5--81.0)        12                          52.9 (40.5--69.0)              \< 0.0001                   
  2012                     325    55.2^§,∥^ (52.4--58.1)     394                         73.0^§^ (69.0--77.3)        293                       70.3^∥^ (65.3--75.8)        13                          53.6 (39.3--73.0)              \< 0.0001                   
  2013                     340    56.9^§,∥^ (53.7--60.3)     433                         77.4^§^ (73.1--82.0)        311                       71.5^∥^ (66.4--77.0)        15                          53.2 (40.4--70.1)              \< 0.0001                   
  Triglyceride             2010   312                        37.1^§,\|^\| (34.2--40.2)   304                         45.0^§^ (41.3--49.0)      269                         45.0^∥^ (41.4--48.9)        11                             35.8 (21.5--59.8)           0.0023
  2011                     318    39.8^§,∥^ (36.8--43.0)     341                         47.2^§^ (43.4--51.3)        305                       48.1^∥^ (44.4--52.2)        12                          35.3 (19.4--64.2)              0.0029                      
  2012                     310    36.4^§,∥^ (33.8--39.3)     301                         45.0^§^ (41.3--49.1)        259                       44.6^∥^ (41.1--48.5)        11                          34.0 (21.0--55.0)              0.0005                      
  2013                     349    35.3^§,∥^ (32.8--38.0)     439                         45.7^§,¶^ (42.6--49.0)      347                       44.4^∥,\*\*^ (41.4--47.5)   15                          26.1^¶,\*\*^ (21.5--31.8)      \< 0.0001                   
  Uric acid                2010   311                        34.4^§,∥^ (32.4--36.6)      281                         45.5^§^ (42.2--49.1)      207                         43.5^∥^ (39.3--48.2)        11                             33.3 (25.7--43.3)           \< 0.0001
  2011                     318    31.8^§,∥^ (30.1--33.6)     315                         43.0^§^ (40.2--46.0)        225                       42.7^∥^ (38.7--47.1)        11                          35.5 (24.2--52.0)              \< 0.0001                   
  2012                     322    30.1^§,∥^ (28.4--31.8)     352                         43.7^§,¶^ (41.0--46.6)      236                       39.3^∥^ (35.7--43.2)        13                          26.3^¶^ (20.4--33.9)           \< 0.0001                   
  2013                     346    33.0^§,∥^ (31.0--35.2)     386                         45.7^§,¶^ (42.8--48.8)      245                       40.8^∥,\*\*^ (37.2--44.7)   15                          24.6^¶,\*\*^ (19.4--31.1)      \< 0.0001                   

^\*^Number of laboratories; ^†^Geometric mean of the VIS; ^‡^*P* value represents overall differences across groups as determined by ANOVA using log-transformed values; ^§,\ ∥,\ ¶,\ \*\*,\ ††^Matching letters indicate statistical significance based on Tukey\'s multiple comparison.

Abbreviations: see [Table 1](#T1){ref-type="table"}.

###### Comparison of variance index scores between laboratories in the general hospital group between 2010 and 2013

![](alm-37-213-i003)

  Test item                Year   Accredited laboratory   Non-accredited laboratory   *P*^‡^                                      
  ------------------------ ------ ----------------------- --------------------------- --------------------- --------------------- -----------
  Albumin                  2010   205                     40.8 (38.5--43.4)           108                   47.5 (43.5--52.0)     0.0045
  2011                     212    36.4 (34.1--38.9)       108                         39.6 (36.0--43.6)     0.1534                
  2012                     219    36.5 (34.3--38.9)       105                         38.3 (34.9--42.1)     0.3865                
  2013                     221    37.6 (35.4--39.9)       124                         43.9 (39.8--48.6)     0.0080                
  ALP                      2010   203                     39.3 (36.0--43.0)           109                   45.4 (38.5--53.6)     0.1310
  2011                     210    40.3 (37.0--44.0)       109                         49.1 (42.5--56.6)     0.0209                
  2012                     217    39.9 (36.5--43.6)       106                         42.9 (36.5--50.4)     0.4376                
  2013                     219    43.4 (39.6--47.5)       121                         53.1 (45.5--61.9)     0.0262                
  ALT                      2010   205                     33.9 (31.7--36.3)           116                   35.0 (31.2--39.2)     0.6480
  2011                     212    29.1 (27.2--31.3)       116                         37.4 (33.8--41.4)     \< 0.0001             
  2012                     219    33.4 (31.3--35.6)       113                         39.6 (36.0--43.5)     0.0028                
  2013                     221    34.0 (31.6--36.5)       135                         39.6 (35.8--43.9)     0.0130                
  AST                      2010   205                     30.0 (27.9--32.2)           116                   33.4 (30.3--36.8)     0.0794
  2011                     212    27.3 (25.5--29.3)       116                         29.8 (26.7--33.2)     0.1722                
  2012                     219    27.7 (25.7--29.8)       113                         30.8 (27.9--34.0)     0.0914                
  2013                     221    28.0 (26.0--30.1)       134                         32.6 (29.2--36.4)     0.0199                
  BUN                      2010   205                     46.9 (43.8--50.3)           109                   60.2 (54.3--66.8)     \< 0.0001
  2011                     212    41.2 (38.7--43.9)       109                         58.4 (52.6--64.8)     \< 0.0001             
  2012                     219    42.2 (39.7--45.0)       106                         51.4 (46.9--56.3)     0.0005                
  2013                     221    42.3 (39.7--45.1)       130                         59.7 (53.3--66.8)     \< 0.0001             
  Chloride                 2010   203                     76.0 (71.2--81.1)           103                   103.9 (94.2--114.5)   \< 0.0001
  2011                     210    74.7 (71.2--78.5)       103                         93.4 (86.3--101.2)    \< 0.0001             
  2012                     217    77.5 (73.6--81.7)       99                          104.2 (95.5--113.7)   \< 0.0001             
  2013                     219    83.1 (79.0--87.4)       104                         100.2 (91.7--109.5)   0.0004                
  Creatinine               2010   203                     44.8 (41.9--47.9)           110                   57.1 (51.8--62.9)     \< 0.0001
  2011                     210    45.2 (42.4--48.1)       110                         51.9 (46.8--57.5)     0.0257                
  2012                     217    45.1 (42.5--47.9)       107                         56.5 (50.6--63.1)     0.0005                
  2013                     219    45.6 (43.0--48.3)       131                         61.5 (54.8--69.0)     \< 0.0001             
  γ-glutamyl transferase   2010   203                     27.7 (25.6--29.9)           110                   36.5 (32.8--40.6)     \< 0.0001
  2011                     210    27.8 (25.7--30.0)       110                         29.1 (26.0--32.6)     0.5024                
  2012                     217    28.5 (26.5--30.6)       107                         31.2 (27.9--34.8)     0.1758                
  2013                     219    27.9 (26.0--29.9)       131                         35.3 (31.6--39.4)     0.0004                
  Glucose                  2010   203                     23.2 (21.7--24.9)           110                   34.3 (30.7--38.3)     \< 0.0001
  2011                     210    23.2 (21.8--24.7)       110                         30.3 (27.4--33.6)     \< 0.0001             
  2012                     217    23.8 (22.2--25.4)       107                         31.3 (28.0--35.1)     \< 0.0001             
  2013                     219    22.1 (20.6--23.8)       131                         34.5 (30.6--38.9)     \< 0.0001             
  LDH                      2010   201                     15.2 (13.5--17.1)           106                   21.7 (17.9--26.4)     0.0021
  2011                     208    13.2 (12.0--14.6)       104                         19.2 (16.1--23.0)     0.0004                
  2012                     214    14.0 (12.9--15.2)       101                         18.1 (15.4--21.4)     0.0064                
  2013                     216    17.1 (15.8--18.5)       111                         24.3 (20.6--28.7)     0.0002                
  Phosphorus               2010   198                     32.9 (30.6--35.4)           89                    43.4 (38.0--49.4)     0.0001
  2011                     205    29.2 (27.2--31.4)       88                          40.1 (35.1--45.8)     \< 0.0001             
  2012                     214    29.4 (27.4--31.7)       84                          37.9 (32.6--44.1)     0.0033                
  2013                     217    29.0 (27.0--31.2)       86                          36.7 (32.1--42.0)     0.0011                
  Potassium                2010   203                     48.4 (45.1--51.9)           103                   63.0 (56.5--70.2)     \< 0.0001
  2011                     210    44.4 (41.4--47.6)       103                         63.1 (56.6--70.3)     \< 0.0001             
  2012                     216    44.0 (41.5--46.7)       99                          60.4 (53.9--67.7)     \< 0.0001             
  2013                     218    41.9 (39.0--45.1)       104                         56.8 (50.9--63.4)     \< 0.0001             
  Sodium                   2010   203                     59.5 (55.3--64.0)           103                   73.7 (66.0--82.3)     0.0011
  2011                     210    59.7 (56.0--63.6)       103                         78.5 (70.0--88.0)     \< 0.0001             
  2012                     217    57.2 (54.0--60.6)       99                          76.9 (68.9--85.9)     \< 0.0001             
  2013                     219    54.4 (51.1--58.0)       104                         72.9 (65.9--80.7)     \< 0.0001             
  Total bilirubin          2010   203                     25.6 (23.6--27.8)           109                   28.6 (25.2--32.4)     0.1378
  2011                     210    27.6 (25.5--29.9)       109                         31.0 (27.7--34.7)     0.0926                
  2012                     217    26.8 (24.7--29.1)       106                         27.5 (24.3--31.2)     0.7206                
  2013                     219    26.0 (24.0--28.2)       129                         32.6 (28.7--37.2)     0.0036                
  Total calcium            2010   200                     52.9 (49.2--57.0)           95                    69.7 (62.7--77.5)     \< 0.0001
  2011                     208    51.8 (48.5--55.3)       94                          72.8 (66.0--80.3)     \< 0.0001             
  2012                     216    53.3 (49.8--57.1)       89                          69.2 (62.9--76.1)     \< 0.0001             
  2013                     217    48.7 (45.7--52.1)       95                          60.5 (53.6--68.4)     0.0024                
  Total cholesterol        2010   205                     27.8 (25.9--29.7)           110                   32.1 (28.9--35.6)     0.0188
  2011                     212    26.0 (24.3--27.9)       110                         33.7 (30.8--36.8)     \< 0.0001             
  2012                     219    25.7 (24.1--27.5)       105                         31.6 (28.4--35.3)     0.0007                
  2013                     221    26.4 (24.8--28.0)       131                         37.5 (33.3--42.1)     \< 0.0001             
  Total protein            2010   205                     57.1 (53.1--61.4)           109                   62.9 (56.3--70.4)     0.1389
  2011                     212    53.4 (50.6--56.4)       109                         70.9 (64.4--78.1)     \< 0.0001             
  2012                     219    50.9 (47.9--54.0)       106                         65.1 (59.2--71.7)     \< 0.0001             
  2013                     221    50.5 (47.5--53.7)       119                         71.0 (63.5--79.3)     \< 0.0001             
  Triglyceride             2010   203                     32.2 (29.3--35.3)           109                   48.5 (42.0--55.9)     \< 0.0001
  2011                     210    35.3 (32.5--38.3)       108                         50.3 (43.1--58.7)     \< 0.0001             
  2012                     212    32.7 (30.0--35.5)       98                          46.2 (39.8--53.6)     \< 0.0001             
  2013                     219    29.4 (27.3--31.7)       130                         47.9 (41.7--54.9)     \< 0.0001             
  Uric acid                2010   203                     32.4 (30.2--34.7)           108                   38.6 (34.4--43.2)     0.0100
  2011                     210    29.7 (27.7--31.7)       108                         36.5 (33.3--40.0)     0.0005                
  2012                     217    28.0 (26.2--29.9)       105                         34.9 (31.6--38.5)     0.0003                
  2013                     219    28.0 (26.3--29.9)       127                         43.7 (38.8--49.3)     \< 0.0001             

^\*^Number of laboratories; ^†^Geometric mean of the VIS; ^‡^*P* value by Student\'s t-test using log-transformed values.

Abbreviations: see [Table 1](#T1){ref-type="table"}.

[^1]: ^\*^These two authors contributed equally to this manuscript.
